26.08.2013 Views

Endogenous allergen assessments - Europabio

Endogenous allergen assessments - Europabio

Endogenous allergen assessments - Europabio

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Design, relevance and limitations of<br />

current endogenous <strong>allergen</strong><br />

<strong>assessments</strong><br />

Scott McClain, Ph.D.<br />

Syngenta Crop Protection, LLC<br />

Research Triangle Park, NC USA


Design of studies is based, in part, on available<br />

technology<br />

2<br />

-Serologydetection<br />

of <strong>allergen</strong>s<br />

with patient IgE or<br />

animal IgG antibody<br />

-Protein Separation-<br />

Visualize individual<br />

proteins with<br />

stains/serum IgE using<br />

electrophoresis as a<br />

foundation<br />

-Analytical-<br />

Mass spectrometry<br />

is the newest<br />

multiplexing,<br />

quantitative<br />

methodology


IgE, ug/ml<br />

Question: Are <strong>Endogenous</strong> Allergens in Biotech Crops<br />

Increased Relative to Their non-GM Counterparts?<br />

● Has been applied to GM soybean because soybean is considered a<br />

major <strong>allergen</strong>ic food<br />

● Traditionally, the technology available was based on serology:<br />

3<br />

- Use soybean allergic sera as a detection reagent for <strong>allergen</strong>-IgE<br />

binding - measure <strong>allergen</strong> content.<br />

• Total anti-soybean IgE binding ELISA – measures IgE that is specific<br />

to “all” of the <strong>allergen</strong>s a person may be responsive to; quantitatively,<br />

if validated.<br />

• Gel Electrophoresis and Western blotting; can observe binding to<br />

multiple, individual <strong>allergen</strong>s.<br />

Total<br />

IgE<br />

To discriminate individual <strong>allergen</strong>s by ELISA with<br />

serum, individual ELISAs with protein standards<br />

would need to be validated – for soybean this<br />

would minimally be > 8 separate assays*.<br />

Allergen #1<br />

* - University of Nebraska, FARRP <strong>allergen</strong>online.org


Protein Separation and Western Blotting<br />

● Western blotting (WB), and in particular 2-dimensional WB, is of<br />

interest for observing individual proteins<br />

4<br />

- A qualitative observation of the proteins binding serum IgE antibody.<br />

• Although “spots” can be optically measured in general, the<br />

technique is considered semi-quantitative since there are<br />

no standard curves assessed for individual <strong>allergen</strong>s (in<br />

most cases).<br />

- Also perceived as beneficial for observing “new” <strong>allergen</strong>s that<br />

may be present in GM variety…<br />

this is improbable given that new varieties are assessed<br />

prior to market release and exposure. There is also no<br />

premise for new proteins, much less new <strong>allergen</strong>s being<br />

created by introduction of GM trait(s).


2-D Electrophoresis and Western Blotting<br />

Total protein stain shown – Red circle indicates observable soybean proteins by Western<br />

5<br />

Gel Electrophoretic pattern<br />

Taken from Batista et al., 2007. Int Arch Allergy Immunol 2007;144:29–38<br />

IgE reactivity to all of the<br />

possible soybean<br />

<strong>allergen</strong>s is very limited<br />

in a single serum


Considerations for Serology Based Studies<br />

6<br />

Primary Limitation – limited availability of well-characterized sera.<br />

- Variability in IgE binding across one or more proteins among different<br />

patients.<br />

• Not all patients have IgE against a given <strong>allergen</strong> of the same<br />

affinity – thus, quantitative determinations are limited.<br />

- Soybean has many <strong>allergen</strong>s, so thoroughly characterizing the exact<br />

same set of proteins with good reproducibility from one study to the<br />

next is not possible since sera will vary temporally among patients.<br />

- Virtually impossible to have same set of patient sera form one study to<br />

next


Liquid Chromatography MS/MS for Protein<br />

Identification<br />

7<br />

1. Proteins are digested into peptides<br />

2. Peptides are separated to reduce complexity<br />

3. Peptides are “weighed” and sequenced by mass spectrometry<br />

4. Peptide sequence provides protein identification through bioinformatics<br />

S.E. Stevenson, Houston N., and Thelen J. 2010. Regul. Toxicol. Pharmacol.<br />

58, 3, S36-41.


AQUA® Peptide Analysis by MS to Quantify Proteins<br />

Two different<br />

isotopes to label<br />

amino acids<br />

These labeled<br />

(heavier) peptides<br />

can then act as<br />

peptide<br />

Standards<br />

Isotope labeled<br />

Native peptide<br />

AQUA peptide<br />

8<br />

H 2N<br />

H 2N<br />

HO<br />

C<br />

NH<br />

CH 2<br />

CH 2<br />

CH 2<br />

CH<br />

C O<br />

NH<br />

Arginine (R) – 174.2<br />

13 C6H 14 15 N4O 2 – 184.2<br />

1 2<br />

H 2N<br />

HO<br />

NH 2<br />

CH 2<br />

CH 2<br />

CH 2<br />

CH 2<br />

CH<br />

C O<br />

Lysine (K) – 146.19<br />

13 C6H 14 15 N2O 2 – 154.19<br />

LSAEFGSLR – 978.51 VSDDEFNNYK – 1229.52<br />

LSAEFGSLR – 988.51 VSDDEFNNYK – 1237.52


Aqua® Peptides and Quantifying; How does it work?<br />

9<br />

Seed <strong>allergen</strong> peptide (previously identified)<br />

signal<br />

Mix label<br />

with seed<br />

prep<br />

mass<br />

Labeled peptide standard<br />

+<br />

mass spectrometry can distinguish them<br />

+<br />

+<br />

Known amount of<br />

standard added<br />

Ratio gives quantity


Relevance of the Study Design for <strong>Endogenous</strong><br />

Allergen Content<br />

● Premise:<br />

10<br />

- <strong>Endogenous</strong> <strong>allergen</strong>s could, by some unknown mechanism, be<br />

influenced to express at a higher level in GM-traited soybean crops<br />

compared with non-GM<br />

- Soybean – although soybean has many <strong>allergen</strong>s, including<br />

abundant seed storage proteins, the threshold exposure to individual<br />

<strong>allergen</strong>s is not known.<br />

• Therefore, at this point in time, there is no knowledge of how<br />

many µg or mg of an <strong>allergen</strong> is significant from an allergy safety<br />

perspective –<br />

• this in turn limits the study design - a single comparison of GM<br />

versus non-GM control is not useful<br />

- The only relevant study that can be designed is to survey several<br />

non-GM references so there is context to the study in terms of the<br />

natural range of expression for one or more <strong>allergen</strong>s.


µg <strong>allergen</strong> protein/mg total protein<br />

Example – Observing Allergens in the Context of<br />

a Population of Non-GM Varieties (References)<br />

11<br />

120<br />

100<br />

80<br />

60<br />

40<br />

The difference is small<br />

relative to the variability<br />

in the references<br />

GlyG1<br />

GlyG2<br />

Allergen<br />

Test<br />

Control<br />

upper TI<br />

lower TI<br />

Many references can be used to<br />

show the probable range of<br />

expression for a population<br />

The differences between the GM<br />

“test” and its non-GM” control can<br />

then be assessed against the natural<br />

variability in <strong>allergen</strong> expression<br />

Conclusion – in this case, both<br />

<strong>allergen</strong>s show small differences for<br />

the GM variety that are not<br />

biologically relevant


Allergen Context: Understanding Natural Variability<br />

12<br />

Many non-GM reference samples help establish<br />

the concentration range for a new protein (i.e.,<br />

<strong>allergen</strong>) that has clinical implications; particularly<br />

when employing quantitative approaches<br />

Why is this important ?<br />

ug of <strong>allergen</strong> per mg protein<br />

If a protein is being characterized<br />

for the first time, it is critical to<br />

validate the population for its<br />

“normal” content<br />

In the future – the quantity of an<br />

<strong>allergen</strong> could potentially be<br />

correlated to threshold exposure<br />

levels to understand allergy<br />

impact


Soybeans<br />

13<br />

Glycine max<br />

Yes, it’s an<br />

<strong>allergen</strong>ic food<br />

But,<br />

We don’t know how much or<br />

how little causes allergy for<br />

any one of the many protein<br />

<strong>allergen</strong>s<br />

And,<br />

We don’t have evidence that<br />

GM varieties would be<br />

expected to differ in their<br />

<strong>allergen</strong> content<br />

For now,<br />

We can assess GM and<br />

non-GM, but not in<br />

isolation<br />

Small differences are<br />

unlikely to be relevant to<br />

allergy risk – Therefore,<br />

we need to understand<br />

small differences as best<br />

as we can<br />

We cannot predict endogenous<br />

allergy risk relative to a<br />

measured amount of protein…<br />

So, any assessment has to<br />

include a population of<br />

references to understand the<br />

natural variability for any single<br />

<strong>allergen</strong>


<strong>Endogenous</strong> Allergen Approaches<br />

● Question: Are <strong>Endogenous</strong> Allergens in Biotech Crops<br />

Increased Relative to Their non-GM Counterparts?<br />

● Question implies that the target protein(s) can be quantitatively<br />

measured with relevance to allergy risk<br />

14<br />

- ILSI/HESI protein <strong>allergen</strong>icity tech committee has<br />

supported work to use quantitative approaches to provide<br />

measures of soybean <strong>allergen</strong>s<br />

● Methods may include qualitative or quantitative<br />

approaches<br />

● Methods should be:<br />

• Sensitive<br />

• Specific<br />

• Reproducible


Relevance of the data – Can this data be<br />

interpreted for allergy risk?<br />

● Can we measure <strong>allergen</strong>s?<br />

15<br />

- Yes, ability is increasing all the time and with increasing sensitivity<br />

● What is the relevance to the population in terms of their risk for allergy?<br />

- Most <strong>allergen</strong>s still require further study to characterize their<br />

sensitization potential and the amount that causes clinical allergy<br />

- There is no existing hypothesis for a change to endogenous allergy<br />

risk based on GM varieties<br />

● So, even though we have the ability to measure <strong>allergen</strong> content the<br />

question remains – have we added value to the <strong>allergen</strong>icity<br />

assessment?


Contributing EuropaBio Member Companies<br />

● Bayer CropScience<br />

● BASF<br />

● Dow AgroSciences<br />

● Dupont Pioneer<br />

● Monsanto<br />

● Syngenta<br />

16


Questions and Discussion<br />

● Thank your for your attention<br />

17

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!